LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(0%)
LAVA Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(7.9%),Jeremy C. Green(7.9%), etc.
LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(7.1%)
LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(9.13%)
LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(11.7%)
LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(12.9%)
LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(8.6%)
LAVA Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(10.9%),Jeremy C. Green(10.9%), etc.
LAVA Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
LAVA Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
LAVA Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
LAVA Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
LAVA Therapeutics | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities